Mina Lobbous MD

PubMed

• 3 citations
  Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US.
  Tianqi Xiao, Pranav Kumar, Mina Lobbous, Divya Yogi-Morren, Pranay Soni
  JAMA Neurology. 2025-11-01
• Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparin.
  Radhika S Amin, Scott Cameron, Matthew M Grabowski, Justin D Lathia, Mina Lobbous
  Neuro-Oncology Advances. 2025-09-13
• 1 citations
  Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial.
  Andrea M Gross, Olivia H Reid, Lauren A Baldwin, Ashley Cannon, Hyoyoung Choo-Wosoba
  JAMA Dermatology. 2025-02-26

Journal Articles

• An evaluation of selumetinib for the treatment of neurofibromatosis type 1-associated symptomatic, inoperable plexiform neurofibromas  
  Katie Metrock, Mina Lobbous, Bruce Korf, Expert Review of Precision Medicine and Drug Development, 7/2021

Books/Book Chapters

• UpToDate 
  Chapter: Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis 
  Bruce Korf, Mina Lobbous, Katie MetrockEditors: Marc C Patterson, Helen V Firth, April F Eichler..Waltham, MA
• UpToDate 
  Chapter: Neurofibromatosis type 1 (NF1): Management and prognosis 
  Bruce Korf, Mina Lobbous, Katie MetrockEditors: Marc C Patterson, Helen V Firth, April F Eichler..Waltham, MA
• Neurofibromatosis: Current Trends and Future Directions 
  Chapter: Therapeutic development in neurofibromatosis. 
  Page 85 - 99Mina Lobbous, Bruce KorfEditors: Francesco Signorelli and Raffaella Messina.IntechOpen, London, UK2019

Abstracts/Posters

• Phase 1 trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma
  Louis B. Nabors, Lawrence S. Lamb, Melissa Jo Beelen, Thriumaine Pillay, Mariska ter Haak, Samantha Youngblood, Louis Vaickus, Mina Lobbous, ASCO 2021
• Pharmacokinetic (PK) analyses in CSF and plasma from TBCRC049, an ongoing trial to assess the safety and efficacy of the combination of tucatinib, trastuzumab and cape...
  Erica Michelle Stringer-Reasor, Barbara Jane O'Brien, Ariel Topletz-Erickson, Jason B White, Mina Lobbous, Kristen Riley, Jennifer Childress, Kim LaMaster, Michelle E...., ASCO 2021
• Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001
  Katherine B. Peters, John L. Villano, Nicholas A. Butowski, Adam Louis Cohen, Joe Sammy Mendez, Pierre Giglio, Chi Zhang, Shahzad Raza, Tresa McGranahan, Mina Lobbous,..., ASCO 2021

Other

• Prevalence of asymptomatic glioma and implications for survival 
  Warren PP, Lobbous M, Peeri NC, Thompson ZJ, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Anderson MD, Vogelbaum MA, Markert JM, Nabors LB, Egan KM
  https://www.medrxiv.org/content/10.1101/2020.04.27.20080564v1
  MedRxiv - 2020